Medication info
Esryptin Tablet 50mg (Sitagliptin Hydrochloride Monohydrate)

Esryptin Tablet 50mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.7mg / 1 tablet
Manufacturer / importer
Withus Pharm Co., Ltd.
Appearance
Light yellow pink, round, biconvex, film-coated tablet
Packaging
30 tablets - 10 tablets/PTP[x3]
Approval status
Active

MFDS item code 202004029 · Approved 2020.05.29 · Insurance code 660703780

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken without regard to meals. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia caused by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is necessary, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Withus Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes who are adhering to dietary and exercise regimens. It can be administered alone and can be used in combination with metformin when blood sugar control is difficult to achieve with monotherapy in cases with no prior experience with diabetes medications. Additionally, it can be used in combination with existing therapies like sulfonylureas, metformin, thiazolidinediones, and insulin when adequate blood sugar control is not achieved. This medication helps manage blood sugar effectively in conjunction with other medications. Therefore, it is used to improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

This medicine is administered at 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken without regard to meals. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia caused by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is necessary, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Precautions

This medication may cause allergic reactions; if symptoms such as hives, rashes, or difficulty breathing occur, immediately discontinue use and consult a physician. During treatment, serious inflammation of the pancreas known as pancreatitis may occur; seek immediate medical attention if you experience abdominal pain, vomiting, or severe discomfort. This medication should not be used by patients with type 1 diabetes or diabetic ketoacidosis, and use should be avoided in those with allergies to this medication or its components. Patients with decreased renal function should adjust the dosage of this medication according to their physician's instructions, and regular monitoring of renal function is important. While taking this medication, side effects such as cold symptoms, headaches, and digestive disorders may occur, particularly if taken in conjunction with insulin or sulfonylureas where hypoglycemia may occur more frequently. It is recommended that pregnant or breastfeeding women avoid this medication, and safety and efficacy have not been established in children and adolescents under 18 years old. Elderly patients may experience decreased renal function, necessitating dosage adjustments and monitoring of renal function. In case of overdose, immediate medical attention should be sought, and blood dialysis may be considered if necessary. The risk of hypoglycemia may increase when used with other blood sugar-lowering agents; adjustments to the dosage of co-administered medications may be necessary. If you experience severe joint pain or blisters on the skin, notify your physician immediately and cease use to receive professional treatment. This medication typically does not have a significant effect on cardiovascular health; however, patients with pre-existing cardiovascular conditions require regular check-ups. Discuss with your physician before and after taking this medication to confirm your health status and the interactions with other medications you are taking.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infections
  • nasopharyngitis
  • headaches
  • diarrhea
Show 28 more
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased blood triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, preferably at room temperature between 1°C and 30°C. Proper storage helps maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Light yellow pink, round, biconvex, film-coated tablet

Package unit

30 tablets - 10 tablets/PTP[x3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.